Trial intelligence / Profile preview

Aspirin dosing in type 2 diabetes mellitus

NCT00812032Phase 4Completed

Sponsor
Karolinska Institutet
Start
Jan 2008
Primary completion
Oct 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in cardiovascular disease (CVD), sponsored by Karolinska Institutet. Started Jan 2008; status: completed.

02

Drugs

aspirin
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT00812032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00812032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call